This information is for educational and research purposes only. Always consult qualified healthcare professionals before beginning any peptide protocol.
Overview
CJC-1295 + Ipamorelin is a highly effective peptide combination designed to stimulate the body's natural growth hormone (GH) release in a controlled and sustained manner. CJC-1295 (a GHRH analog) increases the amplitude and duration of GH pulses by stimulating GHRH receptors in the pituitary gland, while Ipamorelin (a ghrelin receptor agonist) enhances the frequency of GH release without significantly raising cortisol or prolactin. This synergy creates an optimal anabolic environment for muscle growth, fat loss, and recovery.
Key Benefits
- •Increases natural growth hormone production through dual-pathway stimulation
- •Promotes fat loss while preserving and building lean muscle mass
- •Improves sleep quality and recovery, particularly deep sleep phases
- •Enhances protein synthesis and cellular growth factors
- •Better recovery between training sessions and reduced inflammation
- •Clean GH release with minimal impact on cortisol or prolactin
- •Sustained GH elevation supporting metabolic health
Dosage Guidelines
Typical Dose
200-300 mcg each peptide
Frequency
1-2x daily (pre-bed recommended, optional AM dose)
Duration
8-12 weeks
Administration
Subcutaneous injection
Research Findings
- •Research indicates a 200-1000% increase in GH levels, significantly enhancing lipolysis and anabolic processes
- •Clinical studies show improved body composition with increased lean mass and reduced fat percentage
- •Users report enhanced sleep architecture with more time spent in restorative deep sleep
- •The combination preserves natural pulsatile GH pattern, reducing receptor desensitization
- •Long-term studies suggest sustained benefits without significant tolerance development when properly cycled
Safety & Considerations
- •Well-tolerated when used at recommended doses
- •May cause water retention and joint stiffness, particularly in early cycles
- •Increased hunger is common, especially with Ipamorelin dosing
- •Monitor IGF-1 levels to avoid excessive GH exposure
- •Potential for carpal tunnel syndrome with long-term or high-dose use
- •Take breaks between cycles (typically 8-12 weeks on, 4-8 weeks off)
- •Not recommended for individuals with active cancer or uncontrolled diabetes
Medical Disclaimer: The information provided is for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Individual results may vary. Always consult with qualified healthcare professionals before beginning any peptide protocol or making health-related decisions.